How would you manage a rising CA-125 in a young patient on maintenance bevacizumab and olaparib x1 year for IIIC HR-deficient serous ovary cancer whose only finding on PETCT is a 1.5cm pelvic lymph node?

How do you prefer to manage an oligometastatic recurrence of high-grade serous ovarian cancer in a patient >12 months out from platinum therapy?

• Continue current regimen until patient symptomatic
• Change systemic therapy regimen
• Refer to Radiation Oncology for targeted RT
• Secondary debulking surgery
• Other